Cost-benefit considerations in the management of uncomplicated urinary tract infections in sexually active women.
D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000627:therapeutic use*; D001437:Bacteriuria; D003362:Cost-Benefit Analysis; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D009520:New Zealand; D012646:Self Administration; D012725:Sexual Behavior; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000191:economics* / Q000382:microbiology
D000892:Anti-Infective Agents, Urinary